← 產業報告目錄

European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-02頁數 477報告編號 MD9504

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The European infection control market is projected to reach USD 20.58 billion by 2030 from USD 14.99 billion in 2025, at a CAGR of 6.6% during the forecast period. The European infection control market is projected to grow at a CAGR of 6.6% during the forecast period. The growth of the market is fuelled by the growing number of surgeries, advancements in reprocessing technologies, the increasing emphasis on sterilization & disinfection of food, advancements in sterilization equipment technology, and the rising trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals. By product & service, the cleaning & disinfection products segment accounted for the largest share of the market in 2024. By product & service, the European infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products. In 2024, the cleaning & disinfection products segment accounted for the largest share of the European infection control market. The large share of this segment is attributed to the rising incidence of chronic diseases, stringent regulatory standards, advancements in sterilization technologies, and the favourable government support for healthcare procedures. By end user, the hospitals & clinics segment accounted for the largest share of the market in 2024. Based on end users, the European infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other end users. The hospitals & clinics segment accounted for the largest share of the European infection control market in 2024. The increasing number of surgical procedures and government initiatives to improve infection prevention and control have prompted greater awareness and implementation of rigorous standards. By country, Germany is expected to dominate the European infection control market during the forecast period. The European infection control market is segmented into 13 countries: Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the rest of Europe. Germany is projected to dominate the market during the forecast period, owing to several reinforcing factors such as strong regulatory backing through national public health initiatives and infection control programs; high healthcare expenditure; and adoption of technologically advanced infection control products, including automated disinfection systems and professional training protocols. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35% • By Designation: C Level: 27%, Director Level: 18%, and Others: 55% Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the European infection control market are STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), and Medline Industries, LP (US), among others. Research Coverage This report studies the European infection control market based on product & service, end user, and countries. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments in 13 countries. Reasons to Buy the Report The report will enable established and entrant/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence. This report provides insights into the following points:  Analysis of key drivers (Rising prevalence of HAIs in Europe, growing number of surgeries, advancement in reprocessing technologies, rising emphasis on sterilization and disinfection of food, advancements in sterilization equipment technology, and the growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals), restraints (growing concerns about safety of reprocessed instruments, consequences associated with use of chemical disinfectants, and the high cost associated with endoscopy reprocessing coupled with limited reimbursements in emerging economies), opportunities (implementation of stringent eu guidelines and mdr compliance and growing utilization of e-beam sterilization), challenges (sterilization of advanced medical devices, alternative methods for surface disinfection, and increasing adoption of single-use medical nonwovens and devices).  Market Penetration: Comprehensive information on the product portfolios offered by the top players in the European infection control market  Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the European infection control market  Market Development: Comprehensive information on lucrative countries  Market Diversification: Exhaustive information about new products and recent developments in the European infection control market  Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.2.1 INCLUSIONS & EXCLUSIONS 36 1.3 MARKET SCOPE 37 1.3.1 MARKETS COVERED 37 1.3.2 REGIONS COVERED 38 1.3.3 YEARS CONSIDERED 38 1.3.4 CURRENCY CONSIDERED 38 1.4 STAKEHOLDERS 38 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH DATA 40 2.1.1 SECONDARY DATA 41 2.1.1.1 Key data from secondary sources 41 2.1.2 PRIMARY DATA 42 2.1.2.1 Primary sources 42 2.1.2.2 Key industry insights 43 2.1.2.3 Key data from primary sources 43 2.1.2.4 Breakdown of primary interviews 44 2.2 MARKET SIZE ESTIMATION 44 2.2.1 BOTTOM-UP APPROACH 45 2.2.1.1 Approach 1: Company revenue estimation approach 45 2.2.1.2 Approach 2: Presentations of companies & primary interviews 46 2.2.1.3 Approach 3: Primary interviews 46 2.2.1.4 Approach 4: Growth forecast 46 2.2.1.5 CAGR projections 46 2.2.2 TOP-DOWN APPROACH 47 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 47 2.4 RESEARCH ASSUMPTIONS 49 2.4.1 STUDY-RELATED ASSUMPTIONS 49 2.4.2 GROWTH RATE ASSUMPTIONS 49 2.5 RISK ASSESSMENT 50 2.6 RESEARCH LIMITATIONS 50 3 EXECUTIVE SUMMARY 51   4 PREMIUM INSIGHTS 55 4.1 EUROPEAN INFECTION CONTROL MARKET OVERVIEW 55 4.2 EUROPEAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY (2024) 56 4.3 EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY, 2025 VS. 2030 57 4.4 EUROPEAN INFECTION CONTROL MARKET: COUNTRY MIX, 2025 VS. 2030 58 5 MARKET OVERVIEW 59 5.1 INTRODUCTION 59 5.2 MARKET DYNAMICS 59 5.2.1 DRIVERS 60 5.2.1.1 Rising prevalence of HAIs 60 5.2.1.2 Increasing number of surgical procedures 61 5.2.1.3 Advancements in reprocessing technologies 62 5.2.1.4 Increasing emphasis on sterilization & disinfection of food 63 5.2.1.5 Advancements in sterilization equipment technology 63 5.2.2 RESTRAINTS 64 5.2.2.1 Growing concerns about safety of reprocessed instruments 64 5.2.2.2 Consequences associated with chemical disinfectant use 65 5.2.2.3 High cost of endoscopy reprocessing and limited reimbursements 66 5.2.3 OPPORTUNITIES 66 5.2.3.1 Implementation of stringent EU guidelines and MDR compliance 66 5.2.3.2 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals 67 5.2.3.3 Growing utilization of E-beam sterilization 67 5.2.4 CHALLENGES 68 5.2.4.1 Sterilization of advanced medical devices 68 5.2.4.2 Alternative methods for surface disinfection 68 5.2.4.3 Increasing adoption of single-use medical devices 69 5.3 PRICING ANALYSIS 69 5.3.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 70 5.3.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022–2024 71 5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2022−2024 71 5.4 VALUE CHAIN ANALYSIS 73 5.4.1 RESEARCH & DEVELOPMENT 73 5.4.2 RAW MATERIAL SUPPLIERS 73 5.4.3 MANUFACTURING 73 5.4.4 DISTRIBUTION 73 5.4.5 MARKETING, AND SALES 73 5.4.6 POST-SALES SERVICES 74   5.5 SUPPLY CHAIN ANALYSIS 74 5.5.1 PROMINENT COMPANIES 74 5.5.2 SMALL & MEDIUM–SIZED ENTERPRISES 75 5.5.3 END USERS 75 5.6 ECOSYSTEM ANALYSIS 75 5.7 TECHNOLOGY ANALYSIS 77 5.7.1 KEY TECHNOLOGIES 77 5.7.1.1 Heat sterilization 77 5.7.1.2 Low-temperature sterilization 77 5.7.2 COMPLEMENTARY TECHNOLOGIES 78 5.7.2.1 Supercritical Co2 technology 78 5.7.2.2 Ultra-high-pressure sterilization 78 5.7.2.3 PEF sterilization 78 5.7.2.4 Plasma sterilization 78 5.8 PORTER’S FIVE FORCES ANALYSIS 79 5.8.1 THREAT OF NEW ENTRANTS 80 5.8.2 THREAT OF SUBSTITUTES 81 5.8.3 BARGAINING POWER OF SUPPLIERS 81 5.8.4 BARGAINING POWER OF BUYERS 81 5.8.5 INTENSITY OF COMPETITIVE RIVALRY 81 5.9 REGULATORY ANALYSIS 81 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 5.9.2 REGULATORY LANDSCAPE 82 5.9.2.1 Europe 82 5.9.2.1.1 Germany 84 5.9.2.1.2 UK 84 5.9.2.1.3 France 84 5.9.2.1.4 Italy 85 5.9.2.1.5 Spain 85 5.10 PATENT ANALYSIS 86 5.11 TRADE ANALYSIS 87 5.11.1 IMPORT DATA FOR HS CODE 841920 88 5.11.2 EXPORT DATA FOR HS CODE 841920 88 5.12 KEY CONFERENCES & EVENTS, 2025–2026 89 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 89 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 90 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 90 5.14.2 BUYING CRITERIA 91 5.15 INVESTMENT & FUNDING SCENARIO 92   5.16 IMPACT OF AI/GENERATIVE AI ON EUROPEAN INFECTION CONTROL MARKET 94 5.16.1 INTRODUCTION 94 5.16.2 POTENTIAL OF AI IN EUROPEAN INFECTION CONTROL MARKET 94 5.16.3 AI USE CASES 95 5.16.4 KEY COMPANIES IMPLEMENTING AI 96 5.16.5 FUTURE OF GENERATIVE AI IN EUROPEAN INFECTION CONTROL MARKET 96 5.17 TRUMP TARIFF IMPACT ON EUROPEAN INFECTION CONTROL MARKET 96 5.17.1 INTRODUCTION 96 5.17.2 KEY TARIFF RATES 97 5.17.3 IMPACT OF TARIFFS ON PRICING 98 5.17.4 KEY IMPACT ON EUROPE 99 5.17.5 END-USER INDUSTRY IMPACT 99 6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE 101 6.1 INTRODUCTION 102 6.2 STERILIZATION PRODUCTS & SERVICES 102 6.2.1 STERILIZATION EQUIPMENT 105 6.2.1.1 Heat sterilization equipment 108 6.2.1.1.1 Moist heat sterilizers 111 6.2.1.1.1.1 Versatility across material testing to fuel market 111 6.2.1.1.2 Dry heat sterilizers 113 6.2.1.1.2.1 Increasing demand for heat-sensitive instruments to boost demand 113 6.2.1.2 Low-temperature sterilization 114 6.2.1.2.1 Hydrogen peroxide sterilization 116 6.2.1.2.1.1 Effective application across broad industries to fuel market 116 6.2.1.2.2 Ethylene oxide (EtO) sterilization 118 6.2.1.2.2.1 High penetration capabilities to fuel uptake 118 6.2.1.2.3 Formaldehyde sterilization 120 6.2.1.2.3.1 Potent antimicrobial properties to aid adoption 120 6.2.1.2.4 Other low-temperature sterilization products 121 6.2.1.3 Radiation sterilization 122 6.2.1.3.1 Utilization across pharmaceutical & biopharmaceutical sectors for vaccines & biologics to drive market 122 6.2.2 CONTRACT STERILIZATION SERVICES MARKET 124 6.2.2.1 EtO sterilization services 126 6.2.2.1.1 Expanding applications across medical device sterilization and life sciences industry to fuel market 126 6.2.2.2 Gamma sterilization services 128 6.2.2.2.1 Minimal chemical residue and ability to penetrate dense materials to fuel uptake 128   6.2.2.3 E-beam sterilization services 130 6.2.2.3.1 Rapid processing and precise control to boost market 130 6.2.2.4 Steam sterilization services 131 6.2.2.4.1 Standard method with optimal efficiency to drive market 131 6.2.2.5 Other contract sterilization services 133 6.2.3 CONSUMABLES & ACCESSORIES 135 6.2.3.1 Sterilization indicators 137 6.2.3.1.1 Chemical indicators 139 6.2.3.1.1.1 Cost-efficiency and simplicity to fuel uptake 139 6.2.3.1.2 Biological indicators 140 6.2.3.1.2.1 Consistent and precise testing features for clinical settings to boost demand 140 6.2.3.2 Sterilization pouches 142 6.2.3.2.1 Sterility maintenance with time duration to aid adoption 142 6.2.3.3 Sterilization lubricants 143 6.2.3.3.1 Prevention of equipment damage to support market growth 143 6.2.3.4 Sterilization accessories 145 6.2.3.4.1 Utilization across healthcare & pharma industries to fuel demand 145 6.3 CLEANING & DISINFECTION PRODUCTS 148 6.3.1 DISINFECTANTS 152 6.3.1.1 Disinfectants, by product type 153 6.3.1.1.1 Hand disinfectants 154 6.3.1.1.1.1 Rising awareness about health & hygiene to boost market 154 6.3.1.1.2 Surface disinfectants 156 6.3.1.1.2.1 Increasing prevalence of HAIs to fuel market 156 6.3.1.1.3 Skin disinfectants 158 6.3.1.1.3.1 Increasing incidence of infectious diseases to fuel market 158 6.3.1.1.4 Instrument disinfectants 160 6.3.1.1.4.1 Growing number of surgical procedures to boost demand 160 6.3.1.2 Disinfectants, by formulation 163 6.3.1.2.1 Liquid disinfectants 163 6.3.1.2.1.1 Effective utilization and high affordability to propel market 163 6.3.1.2.2 Disinfectant wipes 165 6.3.1.2.2.1 Easy accessibility to support market growth 165 6.3.1.2.3 Disinfectant sprays 167 6.3.1.2.3.1 Increasing usage of antimicrobial control measures to fuel demand 167 6.3.1.3 Disinfectants, by EPA classification 169 6.3.1.3.1 Low-level disinfectants 169 6.3.1.3.1.1 Effective elimination of vegetative bacteria and most viruses to boost demand 169 6.3.1.3.2 Intermediate-level disinfectants 170 6.3.1.3.2.1 Applications across dentistry and environmental monitoring to boost demand 170 6.3.1.3.3 High-level disinfectants 171 6.3.1.3.3.1 Sterilization of medical devices and semi-critical instruments across clinical settings to propel uptake 171 6.3.2 CLEANING & DISINFECTION EQUIPMENT 172 6.3.2.1 Washer disinfectors 174 6.3.2.1.1 Utilization of high-pressure water jets and detergents for disinfection to fuel market 174 6.3.2.2 Flusher disinfectors 176 6.3.2.2.1 Innovative product launches to boost demand 176 6.3.2.3 UV-ray disinfectors 178 6.3.2.3.1 Elimination of plethora of viruses, bacteria, and fungi to propel market 178 6.3.2.4 Ultrasonic cleaners 180 6.3.2.4.1 Utilization of high-frequency sound waves for microscopic dirt clearance to aid adoption 180 6.3.2.5 Other cleaning & disinfection equipment 181 6.3.3 LUBRICANTS & CLEANING SOLUTIONS 182 6.3.3.1 Utilization for disinfection of reprocessing instruments to drive market 182 6.3.4 DISINFECTION & CLEANING ACCESSORIES 184 6.3.4.1 Stringent regulatory standards to support market growth 184 6.4 PROTECTIVE BARRIERS 185 6.4.1 MEDICAL NONWOVENS 187 6.4.1.1 Face masks 189 6.4.1.1.1 Increasing prevalence of respiratory diseases to drive market 189 6.4.1.2 Surgical gowns 190 6.4.1.2.1 Growing awareness about infection control to fuel market 190 6.4.1.3 Surgical drapes 192 6.4.1.3.1 Prevention of microorganism transfer from non-sterile surfaces to fuel uptake 192 6.4.2 GLOVES 193 6.4.2.1 Growing concerns related to personnel safety to fuel uptake 193 6.4.3 COVERS & CLOSURES 194 6.4.3.1 Growing focus on food safety to fuel demand 194 6.4.4 GOGGLES 195 6.4.4.1 Increasing use of protective gear in research laboratories to support market growth 195 6.5 ENDOSCOPE REPROCESSING PRODUCTS 196 6.5.1 ENDOSCOPE REPROCESSING CONSUMABLES 199 6.5.1.1 RECURRING NATURE TO FUEL UPTAKE 199 6.5.2 ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS 201 6.5.2.1 Automated endoscope reprocessors 202 6.5.2.1.1 Enhanced efficiency of AERs compared to manual cleaning to fuel uptake 202 6.5.2.2 Endoscope tracking solutions 204 6.5.2.2.1 Ability to provide efficient traceability to fuel uptake 204 6.5.3 OTHER ENDOSCOPE REPROCESSING EQUIPMENT 205 6.6 OTHER INFECTION CONTROL PRODUCTS 207 7 INFECTION CONTROL MARKET, BY END USER 209 7.1 INTRODUCTION 210 7.2 HOSPITALS & CLINICS 210 7.2.1 STRINGENT CLEANLINESS PROTOCOLS FOR RESTRICTION OF HAIS TO PROPEL MARKET 210 7.3 MEDICAL DEVICE COMPANIES 213 7.3.1 RISING TECHNOLOGICAL INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE MARKET 213 7.4 PHARMACEUTICAL COMPANIES 215 7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET 215 7.5 LIFE SCIENCES INDUSTRY 216 7.5.1 INCREASING FOCUS ON CLINICAL RESEARCH INITIATIVES TO FUEL MARKET 216 7.6 FOOD INDUSTRY 218 7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO SUPPORT MARKET GROWTH 218 7.7 OTHER END USERS 219 8 EUROPEAN INFECTION CONTROL MARKET, BY REGION 221 8.1 INTRODUCTION 222 8.2 EUROPE 223 8.2.1 MACROECONOMIC OUTLOOK FOR EUROPE 225 8.2.2 GERMANY 235 8.2.2.1 Growing adoption of hospital disinfection & surveillance systems to drive market 235 8.2.3 UK 244 8.2.3.1 High prevalence of HAIS to drive market 244 8.2.4 FRANCE 254 8.2.4.1 Stringent regulatory guidelines for infection control product commercialization to fuel uptake 254 8.2.5 ITALY 264 8.2.5.1 Increasing establishment of long-term care facilities to boost demand 264 8.2.6 SPAIN 273 8.2.6.1 Increasing prevalence of infectious diseases to fuel market 273 8.2.7 SWITZERLAND 283 8.2.7.1 Heightened burden of CAUTI to drive market 283 8.2.8 POLAND 292 8.2.8.1 Growing volume of surgeries to fuel uptake 292 8.2.9 AUSTRIA 301 8.2.9.1 Rising incidence of notifiable infectious diseases to drive market 301 8.2.10 ROMANIA 311 8.2.10.1 Efficient implementation of disease surveillance systems to boost demand 311 8.2.11 CZECH REPUBLIC 321 8.2.11.1 Growing number of surgical & dental procedures to fuel market 321 8.2.12 SLOVAKIA 330 8.2.12.1 Improvements in healthcare infrastructure to boost demand 330 8.2.13 PORTUGAL 339 8.2.13.1 Rising prevalence of chronic conditions to drive market 339 8.2.14 REST OF EUROPE 348 9 COMPETITIVE LANDSCAPE 359 9.1 INTRODUCTION 359 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 359 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET 359 9.3 REVENUE ANALYSIS, 2020−2024 360 9.4 MARKET SHARE ANALYSIS, 2024 361 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 364 9.5.1 STARS 364 9.5.2 EMERGING LEADERS 364 9.5.3 PERVASIVE PLAYERS 364 9.5.4 PARTICIPANTS 364 9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 366 9.5.5.1 Company footprint 366 9.5.5.2 Region footprint 367 9.5.5.3 Product & service footprint 368 9.5.5.4 End-user footprint 369 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 370 9.6.1 PROGRESSIVE COMPANIES 370 9.6.2 RESPONSIVE COMPANIES 370 9.6.3 DYNAMIC COMPANIES 370 9.6.4 STARTING BLOCKS 370 9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 372 9.6.5.1 Detailed list of key startup/SME players 372 9.6.5.2 Competitive benchmarking of key startups/SMEs 373 9.7 COMPANY VALUATION AND FINANCIAL METRICS 374 9.7.1 FINANCIAL METRICS 374 9.7.2 COMPANY VALUATION 374 9.8 BRAND/PRODUCT COMPARISON 375 9.9 COMPETITIVE SCENARIO 376 9.9.1 PRODUCT LAUNCHES 376 9.9.2 DEALS 377 9.9.3 EXPANSIONS 378 10 COMPANY PROFILES 379 10.1 KEY PLAYERS 379 10.1.1 STERIS 379 10.1.1.1 Business overview 379 10.1.1.2 Products/Services offered 380 10.1.1.3 Recent developments 384 10.1.1.3.1 Deals 384 10.1.1.4 MnM view 384 10.1.1.4.1 Key strengths 384 10.1.1.4.2 Strategic choices 385 10.1.1.4.3 Weaknesses & competitive threats 385 10.1.2 RECKITT BENCKISER 386 10.1.2.1 Business overview 386 10.1.2.2 Products/Services offered 387 10.1.2.3 Recent developments 388 10.1.2.3.1 Deals 388 10.1.2.4 MnM view 388 10.1.2.4.1 Key strengths 388 10.1.2.4.2 Strategic choices 389 10.1.2.4.3 Weaknesses & competitive threats 389 10.1.3 PAUL HARTMANN 390 10.1.3.1 Business overview 390 10.1.3.2 Products/Services offered 391 10.1.3.3 MnM view 392 10.1.3.3.1 Key strengths 392 10.1.3.3.2 Strategic choices 392 10.1.3.3.3 Weaknesses & competitive threats 392 10.1.4 ECOLAB, INC. 393 10.1.4.1 Business overview 393 10.1.4.2 Products/Services offered 394 10.1.4.3 Recent developments 401 10.1.4.3.1 Deals 401 10.1.4.3.2 Product/Service launches 401   10.1.4.4 MnM view 401 10.1.4.4.1 Key strengths 401 10.1.4.4.2 Strategic choices 402 10.1.4.4.3 Weaknesses & competitive threats 402 10.1.5 B. BRAUN SE 403 10.1.5.1 Business overview 403 10.1.5.2 Products/Services offered 404 10.1.5.3 Recent developments 405 10.1.5.3.1 Other developments 405 10.1.5.4 MnM view 405 10.1.5.4.1 Key strengths 405 10.1.5.4.2 Strategic choices 406 10.1.5.4.3 Weaknesses & competitive threats 406 10.1.6 GETINGE AB 407 10.1.6.1 Business overview 407 10.1.6.2 Products/Services offered 408 10.1.6.3 Recent developments 413 10.1.6.3.1 Deals 413 10.1.6.3.2 Product/Service launches 414 10.1.7 ADVANCED STERILIZATION PRODUCTS (SUBSIDIARY OF FORTIVE CORPORATION) 415 10.1.7.1 Business overview 415 10.1.7.2 Products/Services offered 416 10.1.8 SOLVENTUM CORPORATION 418 10.1.8.1 Business overview 418 10.1.8.2 Products/Services offered 419 10.1.9 KIMBERLY-CLARK CORPORATION 424 10.1.9.1 Business overview 424 10.1.9.2 Products/Services offered 425 10.1.10 OLYMPUS CORPORATION 427 10.1.10.1 Business overview 427 10.1.10.2 Products/Services offered 428 10.1.10.3 Recent developments 429 10.1.10.3.1 Deals 429 10.1.10.3.2 Product/Service launches 430 10.1.10.3.3 Other developments 431 10.1.11 CARDINAL HEALTH 432 10.1.11.1 Business overview 432 10.1.11.2 Products/Services offered 433 10.1.11.3 Recent developments 435 10.1.11.3.1 Other developments 435   10.1.12 THE MIELE GROUP (JOINT VENTURE WITH STEELCOBELIMED AG) 436 10.1.12.1 Business overview 436 10.1.12.2 Products/Services offered 436 10.1.12.3 Recent developments 443 10.1.12.3.1 Deals 443 10.1.13 MMM GROUP 444 10.1.13.1 Business overview 444 10.1.13.2 Products/Services offered 444 10.1.13.3 Recent developments 446 10.1.13.3.1 Product/Service launches 446 10.1.14 MATACHANA GROUP 447 10.1.14.1 Business overview 447 10.1.14.2 Products/Services offered 447 10.1.15 MEDLINE INDUSTRIES, LP 450 10.1.15.1 Business overview 450 10.1.15.2 Products/Services offered 450 10.2 OTHER PLAYERS 452 10.2.1 CONTEC, INC. 452 10.2.2 DE LAMA SPA 455 10.2.3 SYSTEC GMBH & CO. KG 456 10.2.4 PAL INTERNATIONAL 457 10.2.5 MELAG MEDIZINTECHNIK GMBH & CO. KG 459 10.2.6 MEDALKAN 460 10.2.7 C.B.M. S.R.L. MEDICAL EQUIPMENT 462 10.2.8 DR. SCHUMACHER GMBH 463 10.2.9 ACTO GMBH 464 10.2.10 ULTRAWAVE 465 11 APPENDIX 466 11.1 DISCUSSION GUIDE 466 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 473 11.3 CUSTOMIZATION OPTIONS 475 11.4 RELATED REPORTS 475 11.5 AUTHOR DETAILS 476
圖表清單 List of Tables & Figures
TABLE 1 EUROPEAN INFECTION CONTROL MARKET: INCLUSIONS & EXCLUSIONS 36 TABLE 2 EUROPEAN INFECTION CONTROL MARKET: RISK ASSESSMENT ANALYSIS 50 TABLE 3 EUROPE: PREVALENCE OF HAIS IN ACUTE CARE HOSPITALS, BY HAI TYPE, 2022–2023 60 TABLE 4 GERMANY: SURGERY TYPES FOR INPATIENT HOSPITAL VISITS, 2023 62 TABLE 5 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 70 TABLE 6 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY REGION, 2022–2024 (USD) 71 TABLE 7 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY TYPE, 2022–2024 (USD) 72 TABLE 8 EUROPEAN INFECTION CONTROL MARKET: ROLE IN ECOSYSTEM 76 TABLE 9 EUROPEAN INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS 79 TABLE 10 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 11 STANDARDS RELATED TO DESIGNATING MEDICAL DEVICES AS STERILE 83 TABLE 12 STERILIZATION STANDARDS IN EUROPEAN UNION 83 TABLE 13 LIST OF PATENTS IN EUROPEAN INFECTION CONTROL MARKET, 2022–2024 87 TABLE 14 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2019–2024 (USD MILLION) 88 TABLE 15 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2019–2024 (USD MILLION) 88 TABLE 16 EUROPEAN INFECTION CONTROL MARKET: KEY CONFERENCES & EVENTS, 2025−2026 89 TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS (%) 91 TABLE 18 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS 92 TABLE 19 ADOPTION OF AI BY KEY INDUSTRY PLAYERS 96 TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES 97 TABLE 21 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 102 TABLE 22 KEY PLAYERS PROVIDING STERILIZATION PRODUCTS 103 TABLE 23 STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 24 EUROPE: STERILIZATION PRODUCTS & SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 25 KEY PLAYERS PROVIDING STERILIZATION EQUIPMENT 106 TABLE 26 STERILIZATION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 107 TABLE 27 EUROPE: STERILIZATION EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 28 KEY PLAYERS PROVIDING HEAT STERILIZATION EQUIPMENT 109 TABLE 29 HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 30 EUROPE: HEAT STERILIZATION EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 31 MOIST HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 111 TABLE 32 EUROPE: MOIST HEAT STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 33 DRY HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 113 TABLE 34 EUROPE: DRY HEAT STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 35 LOW-TEMPERATURE STERILIZERS OFFERED BY KEY MARKET PLAYERS 115 TABLE 36 LOW-TEMPERATURE STERILIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 115 TABLE 37 EUROPE: LOW-TEMPERATURE STERILIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 38 HYDROGEN PEROXIDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 117 TABLE 39 GLOBAL INSTALLED UNITS OF LOW-TEMPERATURE HYDROGEN PEROXIDE GAS PLASMA STERILIZERS, 2023–2030 (UNITS) 117 TABLE 40 EUROPE: HYDROGEN PEROXIDE STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 41 ETO STERILIZERS OFFERED BY KEY MARKET PLAYERS 119 TABLE 42 EUROPE: ETO STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 43 FORMALDEHYDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 120 TABLE 44 EUROPE: FORMALDEHYDE STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 45 EUROPE: OTHER LOW-TEMPERATURE STERILIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 46 RADIATION STERILIZERS OFFERED BY KEY MARKET PLAYERS 123 TABLE 47 EUROPE: RADIATION STERILIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 48 CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 125 TABLE 49 CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 125 TABLE 50 EUROPE: CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 51 ETO STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 127 TABLE 52 EUROPE: ETO STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 53 GAMMA STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 129 TABLE 54 EUROPE: GAMMA STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 55 E-BEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 130 TABLE 56 EUROPE: E-BEAM STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 57 STEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 132 TABLE 58 EUROPE: STEAM STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 59 OTHER CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 134 TABLE 60 EUROPE: OTHER CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 61 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 62 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 63 STERILIZATION INDICATORS OFFERED BY KEY MARKET PLAYERS 137 TABLE 64 STERILIZATION INDICATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138 TABLE 65 EUROPE: STERILIZATION INDICATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 66 CHEMICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 139 TABLE 67 EUROPE: CHEMICAL INDICATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 68 BIOLOGICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 141 TABLE 69 EUROPE: BIOLOGICAL INDICATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 70 STERILIZATION POUCHES OFFERED BY KEY MARKET PLAYERS 142 TABLE 71 EUROPE: STERILIZATION POUCHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 72 STERILIZATION LUBRICANTS OFFERED BY KEY MARKET PLAYERS 144 TABLE 73 EUROPE: STERILIZATION LUBRICANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 74 STERILIZATION ACCESSORIES OFFERED BY KEY MARKET PLAYERS 145 TABLE 75 EUROPE: STERILIZATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 76 CLEANING & DISINFECTION PRODUCTS OFFERED BY KEY MARKET PLAYERS 148 TABLE 77 CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 78 EUROPE: CLEANING & DISINFECTION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 79 COMMON DISINFECTANTS USED IN INDUSTRIAL SETTINGS 152 TABLE 80 EUROPE: DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 81 DISINFECTANTS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 154 TABLE 82 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 155 TABLE 83 EUROPE: HAND DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 84 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 156 TABLE 85 EUROPE: SURFACE DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 86 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 158 TABLE 87 EUROPE: SKIN DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 88 INSTRUMENT DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 161 TABLE 89 EUROPE: INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 90 DISINFECTANTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 163 TABLE 91 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 164 TABLE 92 EUROPE: LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 93 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS 166 TABLE 94 EUROPE: DISINFECTANT WIPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 95 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS 168 TABLE 96 EUROPE: DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 97 DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2023–2030 (USD MILLION) 169 TABLE 98 EUROPE: LOW-LEVEL DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 99 EUROPE: INTERMEDIATE-LEVEL DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 100 EUROPE: HIGH-LEVEL DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 101 CLEANING & DISINFECTION EQUIPMENT OFFERED BY KEY MARKET PLAYERS 173 TABLE 102 CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 103 EUROPE: CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 104 WASHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 175 TABLE 105 EUROPE: WASHER DISINFECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 106 FLUSHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 177 TABLE 107 EUROPE: FLUSHER DISINFECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 108 UV-RAY DISINFECTORS OFFERED BY KEY MARKET PLAYERS 179 TABLE 109 EUROPE: UV-RAY DISINFECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 110 EUROPE: ULTRASONIC CLEANERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 111 EUROPE: OTHER CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 112 LUBRICANTS & CLEANING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 183 TABLE 113 EUROPE: LUBRICANTS & CLEANING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 114 EUROPE: DISINFECTION & CLEANING ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 115 PROTECTIVE BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 116 EUROPE: PROTECTIVE BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 117 MEDICAL NONWOVENS OFFERED BY KEY MARKET PLAYERS 187 TABLE 118 MEDICAL NONWOVENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 119 EUROPE: MEDICAL NONWOVENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 120 EUROPE: FACE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 121 LEVELS OF SURGICAL GOWNS 190 TABLE 122 EUROPE: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 123 EUROPE: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 124 EUROPE: GLOVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 125 EUROPE: COVERS & CLOSURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 126 EUROPE: GOGGLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 127 ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS 197 TABLE 128 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 129 EUROPE: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 130 ENDOSCOPE REPROCESSING CONSUMABLES OFFERED BY KEY MARKET PLAYERS 199 TABLE 131 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 132 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 133 EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 134 AUTOMATED ENDOSCOPE REPROCESSORS OFFERED BY KEY MARKET PLAYERS 203 TABLE 135 EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 136 ENDOSCOPE TRACKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 205 TABLE 137 EUROPE: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 138 OTHER ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS 206 TABLE 139 EUROPE: OTHER ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 140 EUROPE: OTHER INFECTION CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 141 INFECTION CONTROL MARKET, BY END USER, 2023–2030 (USD MILLION) 210 TABLE 142 EXAMPLES OF CRITICAL-ACCESS HOSPITALS IMPLEMENTING EVIDENCE-BASED PROGRAMS FOR HAIS 211 TABLE 143 EUROPE: INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 144 EUROPE: INFECTION CONTROL MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 145 DIFFERENT METHODS OF STERILIZATION IN PHARMACEUTICAL COMPANIES 215 TABLE 146 EUROPE: INFECTION CONTROL MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 147 EUROPE: INFECTION CONTROL MARKET FOR LIFE SCIENCE INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 148 EUROPE: INFECTION CONTROL MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 149 EUROPE: INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 150 EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 151 EUROPE: KEY MACROECONOMIC INDICATORS 225 TABLE 152 EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 226 TABLE 153 EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 154 EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 155 EUROPE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 156 EUROPE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 157 EUROPE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 158 EUROPE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 159 EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 160 EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 161 EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 230 TABLE 162 EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 231 TABLE 163 EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 231 TABLE 164 EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 165 EUROPE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 166 EUROPE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 167 EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 168 EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 169 EUROPE: INFECTION CONTROL MARKET, BY END USER, 2023–2030 (USD MILLION) 234 TABLE 170 GERMANY: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 236 TABLE 171 GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 172 GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 173 GERMANY: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 174 GERMANY: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 175 GERMANY: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 176 GERMANY: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 177 GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 178 GERMANY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 179 GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 240 TABLE 180 GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 241 TABLE 181 GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 241 TABLE 182 GERMANY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 183 GERMANY: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 184 GERMANY: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 185 GERMANY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 186 GERMANY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 187 GERMANY: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 244 TABLE 188 UK: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 246 TABLE 189 UK: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 190 UK: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 191 UK: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 192 UK: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 193 UK: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 194 UK: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 195 UK: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 196 UK: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 197 UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 250 TABLE 198 UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 251 TABLE 199 UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 251 TABLE 200 UK: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 201 UK: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 202 UK: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 203 UK: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 204 UK: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 205 UK: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 254 TABLE 206 FRANCE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 256 TABLE 207 FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 208 FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 209 FRANCE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 210 FRANCE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 211 FRANCE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 212 FRANCE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 213 FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 214 FRANCE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 215 FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 260 TABLE 216 FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 261 TABLE 217 FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 261 TABLE 218 FRANCE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 219 FRANCE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 220 FRANCE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 221 FRANCE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 222 FRANCE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 223 FRANCE: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 264 TABLE 224 ITALY: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 265 TABLE 225 ITALY: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 226 ITALY: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 227 ITALY: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 228 ITALY: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 229 ITALY: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 230 ITALY: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 231 ITALY: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 232 ITALY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 233 ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 269 TABLE 234 ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 270 TABLE 235 ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 270 TABLE 236 ITALY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 237 ITALY: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 238 ITALY: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 239 ITALY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 240 ITALY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 241 ITALY: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 273 TABLE 242 SPAIN: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 275 TABLE 243 SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 244 SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 245 SPAIN: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 246 SPAIN: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 247 SPAIN: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 248 SPAIN: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 249 SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 250 SPAIN: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 251 SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 279 TABLE 252 SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 280 TABLE 253 SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 280 TABLE 254 SPAIN: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 255 SPAIN: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 256 SPAIN: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 257 SPAIN: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 258 SPAIN: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 259 SPAIN: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 283 TABLE 260 SWITZERLAND: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 284 TABLE 261 SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 262 SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 263 SWITZERLAND: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 264 SWITZERLAND: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 265 SWITZERLAND: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 266 SWITZERLAND: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 267 SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 268 SWITZERLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 269 SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 288 TABLE 270 SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 289 TABLE 271 SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 289 TABLE 272 SWITZERLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 273 SWITZERLAND: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 274 SWITZERLAND: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 275 SWITZERLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 276 SWITZERLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 277 SWITZERLAND: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 292 TABLE 278 POLAND: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 293 TABLE 279 POLAND: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 280 POLAND: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 281 POLAND: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 282 POLAND: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 283 POLAND: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 284 POLAND: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 285 POLAND: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 286 POLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 287 POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 297 TABLE 288 POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 298 TABLE 289 POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 298 TABLE 290 POLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 291 POLAND: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 292 POLAND: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 293 POLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 294 POLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 295 POLAND: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 301 TABLE 296 AUSTRIA: REPORTED CASES OF NOTIFIABLE DISEASES 302 TABLE 297 AUSTRIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 303 TABLE 298 AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 299 AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 300 AUSTRIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 301 AUSTRIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 302 AUSTRIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 303 AUSTRIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 304 AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 305 AUSTRIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 306 AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 307 TABLE 307 AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 308 TABLE 308 AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 308 TABLE 309 AUSTRIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 310 AUSTRIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 311 AUSTRIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 312 AUSTRIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 313 AUSTRIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 314 AUSTRIA: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 311 TABLE 315 ROMANIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 313 TABLE 316 ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 317 ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 318 ROMANIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 319 ROMANIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 320 ROMANIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 321 ROMANIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 322 ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 323 ROMANIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 324 ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 317 TABLE 325 ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 318 TABLE 326 ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 318 TABLE 327 ROMANIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 328 ROMANIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 329 ROMANIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 330 ROMANIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 331 ROMANIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 332 ROMANIA: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 321 TABLE 333 CZECH REPUBLIC: NUMBER OF INDEPENDENT SURGERIES (2019─2023) 322 TABLE 334 CZECH REPUBLIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 322 TABLE 335 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 336 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 337 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 338 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 339 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 340 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 341 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 342 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 343 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 326 TABLE 344 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 327 TABLE 345 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 327 TABLE 346 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 347 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 348 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 349 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 350 CZECH REPUBLIC: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 351 CZECH REPUBLIC: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 330 TABLE 352 SLOVAKIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 331 TABLE 353 SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 354 SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 355 SLOVAKIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 356 SLOVAKIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 357 SLOVAKIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 358 SLOVAKIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 359 SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 360 SLOVAKIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 361 SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 335 TABLE 362 SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 336 TABLE 363 SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 336 TABLE 364 SLOVAKIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 365 SLOVAKIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 366 SLOVAKIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 367 SLOVAKIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 368 SLOVAKIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 369 SLOVAKIA: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 339 TABLE 370 PORTUGAL: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 340 TABLE 371 PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 372 PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 373 PORTUGAL: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 374 PORTUGAL: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 375 PORTUGAL: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 376 PORTUGAL: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 377 PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 378 PORTUGAL: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 379 PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 344 TABLE 380 PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 345 TABLE 381 PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 345 TABLE 382 PORTUGAL: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 383 PORTUGAL: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 384 PORTUGAL: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 385 PORTUGAL: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 386 PORTUGAL: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 387 PORTUGAL: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 348 TABLE 388 REST OF EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 350 TABLE 389 REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 390 REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 391 REST OF EUROPE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 392 REST OF EUROPE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 393 REST OF EUROPE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 394 REST OF EUROPE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 395 REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 396 REST OF EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 397 REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 354 TABLE 398 REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION) 355 TABLE 399 REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 355 TABLE 400 REST OF EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 401 REST OF EUROPE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 402 REST OF EUROPE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 403 REST OF EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 404 REST OF EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 405 REST OF EUROPE: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION) 358 TABLE 406 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET 359 TABLE 407 EUROPEAN INFECTION CONTROL MARKET: DEGREE OF COMPETITION 362 TABLE 408 EUROPEAN INFECTION CONTROL MARKET: REGION FOOTPRINT 367 TABLE 409 EUROPEAN INFECTION CONTROL MARKET: PRODUCT & SERVICE FOOTPRINT 368 TABLE 410 EUROPEAN INFECTION CONTROL MARKET: END-USER FOOTPRINT 369 TABLE 411 EUROPEAN INFECTION CONTROL MARKET: DETAILED LIST OF KEY STARTUP/ SME PLAYERS 372 TABLE 412 EUROPEAN INFECTION CONTROL MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 373 TABLE 413 EUROPEAN INFECTION CONTROL MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 376 TABLE 414 EUROPEAN INFECTION CONTROL MARKET: DEALS, JANUARY 2022–JUNE 2025 377 TABLE 415 EUROPEAN INFECTION CONTROL MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 378 TABLE 416 STERIS: COMPANY OVERVIEW 379 TABLE 417 STERIS PLC: PRODUCTS/SERVICES OFFERED 380 TABLE 418 STERIS PLC: DEALS, JANUARY 2022–JUNE 2025 384 TABLE 419 RECKITT BENCKISER: COMPANY OVERVIEW 386 TABLE 420 RECKITT BENCKISER: PRODUCTS/SERVICES OFFERED 387 TABLE 421 RECKITT BENCKISER: DEALS, JANUARY 2022– JUNE 2025 388 TABLE 422 PAUL HARTMANN: COMPANY OVERVIEW 390 TABLE 423 PAUL HARTMANN: PRODUCTS/SERVICES OFFERED 391 TABLE 424 ECOLAB, INC.: COMPANY OVERVIEW 393 TABLE 425 ECOLAB, INC.: PRODUCTS/SERVICES OFFERED 394 TABLE 426 ECOLAB, INC.: DEALS, JANUARY 2021–JUNE 2025 401 TABLE 427 ECOLAB, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 401 TABLE 428 B. BRAUN SE: COMPANY OVERVIEW 403 TABLE 429 B. BRAUN SE: PRODUCTS/SERVICES OFFERED 404 TABLE 430 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 405 TABLE 431 GETINGE AB: COMPANY OVERVIEW 407 TABLE 432 GETINGE AB: PRODUCTS/SERVICES OFFERED 408 TABLE 433 GETINGE AB: DEALS, JANUARY 2022–JUNE 2025 413 TABLE 434 GETINGE AB: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 414 TABLE 435 FORTIVE CORPORATION: COMPANY OVERVIEW 415 TABLE 436 FORTIVE CORPORATION: PRODUCTS/SERVICES OFFERED 416 TABLE 437 SOLVENTUM CORPORATION: COMPANY OVERVIEW 418 TABLE 438 SOLVENTUM CORPORATION: PRODUCTS/SERVICES OFFERED 419 TABLE 439 KIMBERLY CLARK PROFESSIONAL: COMPANY OVERVIEW 424 TABLE 440 KIMBERLY-CLARK CORPORATION: PRODUCTS/SERVICES OFFERED 425 TABLE 441 OLYMPUS CORPORATION: COMPANY OVERVIEW 427 TABLE 442 OLYMPUS CORPORATION: PRODUCTS/SERVICES OFFERED 428 TABLE 443 OLYMPUS CORPORATION: DEALS, JANUARY 2022–JUNE 2025 429 TABLE 444 OLYMPUS CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 430 TABLE 445 OLYMPUS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 431 TABLE 446 CARDINAL HEALTH: COMPANY OVERVIEW 432 TABLE 447 CARDINAL HEALTH: PRODUCTS/SERVICES OFFERED 433 TABLE 448 CARDINAL HEALTH: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 435 TABLE 449 THE MIELE GROUP: COMPANY OVERVIEW 436 TABLE 450 THE MIELE GROUP: PRODUCTS/SERVICES OFFERED 436 TABLE 451 THE MIELE GROUP: DEALS, JANUARY 2022–JUNE 2025 443 TABLE 452 MMM GROUP: COMPANY OVERVIEW 444 TABLE 453 MMM GROUP: PRODUCTS/SERVICES OFFERED 444 TABLE 454 MMM GROUP: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025 446 TABLE 455 MATACHANA GROUP: COMPANY OVERVIEW 447 TABLE 456 MATACHANA GROUP: PRODUCTS/SERVICES OFFERED 447 TABLE 457 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 450 TABLE 458 MEDLINE INDUSTRIES, LP: PRODUCTS/SERVICES OFFERED 450 TABLE 459 CONTEC, INC.: COMPANY OVERVIEW 452 TABLE 460 DE LAMA SPA: COMPANY OVERVIEW 455 TABLE 461 SYSTEC GMBH & CO. KG: COMPANY OVERVIEW 456 TABLE 462 PAL INTERNATIONAL: COMPANY OVERVIEW 457 TABLE 463 MELAG MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 459 TABLE 464 MEDALKAN: COMPANY OVERVIEW 460 TABLE 465 C.B.M. S.R.L. MEDICAL EQUIPMENT: COMPANY OVERVIEW 462 TABLE 466 DR. SCHUMACHER GMBH: COMPANY OVERVIEW 463 TABLE 467 ACTO GMBH: COMPANY OVERVIEW 464 TABLE 468 ULTRAWAVE: COMPANY OVERVIEW 465 FIGURE 1 MARKET SEGMENTATION 37 FIGURE 2 EUROPEAN INFECTION CONTROL MARKET: RESEARCH DESIGN 40 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE AND DESIGNATION 44 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 45 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46 FIGURE 6 EUROPEAN INFECTION CONTROL MARKET: TOP-DOWN APPROACH 47 FIGURE 7 DATA TRIANGULATION METHODOLOGY 48 FIGURE 8 EUROPEAN INFECTION CONTROL MARKET: IMPACT ASSESSMENT ANALYSIS 49 FIGURE 9 EUROPEAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION) 51 FIGURE 10 EUROPEAN INFECTION CONTROL MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 52 FIGURE 11 EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY, 2025 VS. 2030 (USD MILLION) 53 FIGURE 12 RISING INCIDENCE OF HAIS AND STRINGENT IMPLEMENTATION OF INFECTION CONTROL PROTOCOL MEASURES TO PROPEL MARKET 55 FIGURE 13 CLEANING & DISINFECTION PRODUCTS & SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2024 56 FIGURE 14 GERMANY TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 57 FIGURE 15 GERMANY TO DOMINATE MARKET DURING FORECAST PERIOD 58 FIGURE 16 EUROPEAN INFECTION CONTROL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59 FIGURE 17 EUROPEAN INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS 74 FIGURE 18 EUROPEAN INFECTION CONTROL MARKET: SUPPLY CHAIN ANALYSIS 75 FIGURE 19 EUROPEAN INFECTION CONTROL MARKET: ECOSYSTEM MAPPING 76 FIGURE 20 EUROPEAN INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS 80 FIGURE 21 EUROPEAN INFECTION CONTROL MARKET: PATENT ANALYSIS, 2014–2024 86 FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS 91 FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS 92 FIGURE 25 EUROPEAN INFECTION CONTROL MARKET: INVESTMENT & FUNDING ACTIVITIES, 2022−2025 93 FIGURE 26 AI USE CASES 95 FIGURE 27 EUROPE: EUROPEAN INFECTION CONTROL MARKET SNAPSHOT 224 FIGURE 28 ROMANIA: POPULATION AGED 65 & ABOVE (2020−2024) 312 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET, 2020–2024 361 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET (2024) 362 FIGURE 31 EUROPEAN INFECTION CONTROL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 365 FIGURE 32 EUROPEAN INFECTION CONTROL MARKET: COMPANY FOOTPRINT 366 FIGURE 33 EUROPEAN INFECTION CONTROL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 371 FIGURE 34 EV/EBITDA OF KEY VENDORS, 2025 374 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 374 FIGURE 36 EUROPEAN INFECTION CONTROL MARKET: BRAND/PRODUCT COMPARISON 375 FIGURE 37 STERIS PLC: COMPANY SNAPSHOT (2024) 380 FIGURE 38 RECKITT BENCKISER: COMPANY SNAPSHOT (2024) 387 FIGURE 39 PAUL HARTMANN: COMPANY SNAPSHOT (2024) 391 FIGURE 40 ECOLAB, INC.: COMPANY SNAPSHOT (2024) 394 FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2024) 404 FIGURE 42 GETINGE AB: COMPANY SNAPSHOT (2024) 408 FIGURE 43 FORTIVE CORPORATION: COMPANY SNAPSHOT (2024) 416 FIGURE 44 SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024) 419 FIGURE 45 KIMBERLY CLARK CORPORATION: COMPANY SNAPSHOT (2024) 425 FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 428 FIGURE 47 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 433

同分類最新報告(醫療器材)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們